Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ASCO Annual Meeting 2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

2024 ASCO Annual Meeting

Keep up to date with all the top stories and latest evidence with our hub page, including official congress videos and expert takeaways.
ADVANCED SEARCH
Log in
Top
Annals of Surgical Oncology
Published in: Annals of Surgical Oncology 2/2019

01-02-2019 | Urologic Oncology

Important Therapeutic Considerations in T1b Penile Cancer: Prognostic Significance and Adherence to Treatment Guidelines

Authors: Yao Zhu, MD, Wei-Jie Gu, MD, Wen-Jun Xiao, MD, Bei-He Wang, MD, Mounsif Azizi, MD, Philippe E. Spiess, MD, MS, FRCS, FACS(C), Ding-Wei Ye, MD

Published in: Annals of Surgical Oncology | Issue 2/2019

Login to get access

Abstract

Background

The clinical implications and contemporary management of T1b penile cancer are unknown. National treatment guidelines advocate surgical lymph node examination (SLNE) for T1b disease.

Objective

The aim of this study was to evaluate the prognosis of T1b disease and adherence to corresponding treatment guidelines.

Methods

We analyzed 296 patients from two academic centers, and 1263 patients from the Surveillance, Epidemiology, and End Results (SEER) registry (median follow-up 48.3 and 21 months, respectively). Multivariate Cox and Fine–Gray regressions were applied for penile cancer-specific survival (PCSS) analyses.

Results

In the academic center cohort, 28.3% of T1 patients had T1b disease, all of whom underwent SLNE. Nodal metastases were detected in 86.7% of T1b patients and 13.2% of T1a patients (p < 0.001). Using T1a as a reference, PCSS was significantly poorer in the T1b patients, with an adjusted hazard ratio (aHR) of 4.10 (p = 0.03). In the SEER cohort, 16.8% of T1 patients were classified as T1b. SLNE was performed in 21.7% of the T1b patients versus 38.2% of the T2 patients (p = 0.002). The probability of nodal metastases was 2.23-fold higher in T1b patients than in T1a patients (p < 0.001). In clinical N0M0 patients without SLNE, compared with T1a disease, T1b was associated with an aHR of 4.40 and a subdistribution HR of 4.53 for PCSS (both p = 0.003).

Conclusions

T1b penile cancer is strongly associated with nodal metastases and adverse PCSS, and is poorly managed according to guidelines recommended in the nationwide registry.
Appendix
Available only for authorised users
Literature
1.
2.
3.
Zhu Y, Gu WJ, Wang HK, Gu CY, Ye DW. Surgical treatment of primary disease for penile squamous cell carcinoma: a surveillance, epidemiology, and end results database analysis. Oncol Lett. 2015;10(1):85–92.CrossRefPubMedPubMedCentral
4.
Edge S, Byrd DR, Compton CC, Fritz AG, Greene F, Trotti A. AJCC Cancer Staging Handbook. New York: Springer; 2010.
5.
(NCCN) NCCN. NCCN Clinical Practice Guidelines in Oncology. Penile Cancer Version 1.2012.
6.
National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology. Penile Cancer, Version 1.2018.
7.
Ornellas AA, Nobrega BL, Wei Kin Chin E, Wisnescky A, da Silva PC, de Santos Schwindt AB. Prognostic factors in invasive squamous cell carcinoma of the penis: analysis of 196 patients treated at the Brazilian National Cancer Institute. J Urol. 2008;180(4):1354–9.CrossRefPubMed
8.
Graafland NM, Lam W, Leijte JA, et al. Prognostic factors for occult inguinal lymph node involvement in penile carcinoma and assessment of the high-risk EAU subgroup: a two-institution analysis of 342 clinically node-negative patients. Eur Urol. 2010;58(5):742–7.CrossRefPubMed
9.
Zhu Y, Zhang HL, Yao XD, et al. Development and evaluation of a nomogram to predict inguinal lymph node metastasis in patients with penile cancer and clinically negative lymph nodes. J Urol. 2010;184(2):539–45.CrossRefPubMed
10.
Sun M, Djajadiningrat RS, Alnajjar HM, et al. Development and external validation of a prognostic tool for prediction of cancer-specific mortality after complete loco-regional pathological staging for squamous cell carcinoma of the penis. BJU Int. 2015;116(5):734–43.CrossRefPubMed
11.
Sharma P, Djajadiningrat R, Zargar-Shoshtari K, et al. Adjuvant chemotherapy is associated with improved overall survival in pelvic node-positive penile cancer after lymph node dissection: a multi-institutional study. Urol Oncol. 2015;33(11):496 e417-423.CrossRef
12.
Zargar-Shoshtari K, Sharma P, Djajadiningrat R, et al. Extent of pelvic lymph node dissection in penile cancer may impact survival. World J Urol. 2016;34(3):353–9.CrossRefPubMed
13.
Baumgarten A, Chipollini J, Yan S, et al. Penile sparing surgery for penile cancer: a multicenter international retrospective cohort. J Urol. 2018;199(5):1233–7.CrossRefPubMed
14.
15.
Nord H, Segersten U, Sandgren J, et al. Focal amplifications are associated with high grade and recurrences in stage Ta bladder carcinoma. Int J Cancer. 2010;126(6):1390–402.PubMed
16.
Thuret R, Sun M, Abdollah F, et al. Competing-risks analysis in patients with T1 squamous cell carcinoma of the penis. BJU Int. 2013;111(4 Pt B):E174–9.CrossRefPubMed
17.
Kroon BK, Horenblas S, Lont AP, Tanis PJ, Gallee MP, Nieweg OE. Patients with penile carcinoma benefit from immediate resection of clinically occult lymph node metastases. J Urol. 2005;173(3):816–9.CrossRefPubMed
18.
Djajadiningrat RS, Graafland NM, van Werkhoven E, et al. Contemporary management of regional nodes in penile cancer-improvement of survival? J Urol. 2014;191(1):68–73.CrossRefPubMed
19.
Leijte JA, Kirrander P, Antonini N, Windahl T, Horenblas S. Recurrence patterns of squamous cell carcinoma of the penis: recommendations for follow-up based on a two-centre analysis of 700 patients. Eur Urol. 2008;54(1):161–8.CrossRefPubMed
20.
Gopman JM, Djajadiningrat RS, Baumgarten AS, et al. Predicting postoperative complications of inguinal lymph node dissection for penile cancer in an international multicentre cohort. BJU Int. 2015;116(2):196–201.CrossRefPubMed
21.
Matin SF, Cormier JN, Ward JF, et al. Phase 1 prospective evaluation of the oncological adequacy of robotic assisted video-endoscopic inguinal lymphadenectomy in patients with penile carcinoma. BJU Int. 2013;111(7):1068–74.CrossRefPubMedPubMedCentral
22.
Dimopoulos P, Christopoulos P, Shilito S, et al. Dynamic sentinel lymph node biopsy for penile cancer: a comparison between 1- and 2-day protocols. BJU Int. 2016;117(6):890–6.CrossRefPubMed
23.
Joshi SS, Handorf E, Strauss D, et al. Treatment trends and outcomes for patients with lymph node-positive cancer of the penis. JAMA Oncol. 2018;4(5):643–9.CrossRefPubMedPubMedCentral
24.
Hernandez S, Lopez-Knowles E, Lloreta J, et al. Prospective study of FGFR3 mutations as a prognostic factor in nonmuscle invasive urothelial bladder carcinomas. J Clin Oncol. 2006;24(22):3664–71.CrossRefPubMed
25.
Gunia S, Burger M, Hakenberg OW, et al. Inherent grading characteristics of individual pathologists contribute to clinically and prognostically relevant interobserver discordance concerning Broders’ grading of penile squamous cell carcinomas. Urol Int. 2013;90(2):207–13.CrossRefPubMed
26.
Kakies C, Lopez-Beltran A, Comperat E, et al. Reproducibility of histopathologic tumor grading in penile cancer–results of a European project. Virchows Arch. 2014;464(4):453-461.CrossRefPubMed
27.
Velazquez EF, Ayala G, Liu H, et al. Histologic grade and perineural invasion are more important than tumor thickness as predictor of nodal metastasis in penile squamous cell carcinoma invading 5 to 10 mm. Am J Surg Pathol. 2008;32(7):974-979.CrossRefPubMed
28.
Cubilla AL, Velazquez EF, Amin MB, et al. The World Health Organisation 2016 classification of penile carcinomas: a review and update from the International Society of Urological Pathology expert-driven recommendations. Histopathology. 2018;72(6):893–904.CrossRefPubMed
29.
Paner GP, Stadler WM, Hansel DE, Montironi R, Lin DW, Amin MB. Updates in the Eighth Edition of the Tumor-Node-Metastasis Staging Classification for Urologic Cancers. Eur Urol. 2018;73(4):560-569.
Metadata
Title
Important Therapeutic Considerations in T1b Penile Cancer: Prognostic Significance and Adherence to Treatment Guidelines
Authors
Yao Zhu, MD
Wei-Jie Gu, MD
Wen-Jun Xiao, MD
Bei-He Wang, MD
Mounsif Azizi, MD
Philippe E. Spiess, MD, MS, FRCS, FACS(C)
Ding-Wei Ye, MD
Publication date
01-02-2019
Publisher
Springer International Publishing
Published in
Annals of Surgical Oncology / Issue 2/2019
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-018-7066-5

Other articles of this Issue 2/2019

Annals of Surgical Oncology 2/2019 Go to the issue

Head and Neck Oncology

A Multicenter Retrospective Study of Elective Neck Dissection for T1-2N0M0 Tongue Squamous Cell Carcinoma: Analysis Using Propensity Score-Matching

Breast Oncology

Oncotype DX® Recurrence Score as a Predictor of Response to Neoadjuvant Chemotherapy

ASO Author Reflections

ASO Author Reflections: T1b Penile Cancer: An Alarm to Improve Treatment

Breast Oncology

Reply to “Can Patients with Multiple Breast Cancers in the Same Breast Avoid Mastectomy by Having Multiple Lumpectomies to Achieve Equivalent Rates of Local Breast Cancer Recurrence? Response to the Preliminary Alliance 11102 Trial Report”

Gastrointestinal Oncology

Sites of Recurrence After Complete Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Patients with Peritoneal Carcinomatosis from Colorectal and Appendiceal Adenocarcinoma: A Tertiary Center Experience

Urologic Oncology

Combination of the Preoperative Systemic Immune-Inflammation Index and Monocyte-Lymphocyte Ratio as a Novel Prognostic Factor in Patients with Upper-Tract Urothelial Carcinoma